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Abstract
Background: With the ever-increasing information emerging from the various sequencing and gene annotation projects,
there is an urgent need to elucidate the cellular functions of the newly discovered genes. The genetically regulated cell
suicide of apoptosis is especially suitable for such endeavours as it is governed by a vast number of factors.
Methodology/Principal Findings: We have set up a high-throughput screen in 96-well microtiter plates for genes that
induce apoptosis upon their individual transfection into human cells. Upon screening approximately 100,000 cDNA clones
we determined 74 genes that initiate this cellular suicide programme. A thorough bioinformatics analysis of these genes
revealed that 91% are novel apoptosis regulators. Careful sequence analysis and functional annotation showed that the
apoptosis factors exhibit a distinct functional distribution that distinguishes the cell death process from other signalling
pathways. While only a minority of classic signal transducers were determined, a substantial number of the genes fall into
the transporter- and enzyme-category. The apoptosis factors are distributed throughout all cellular organelles and many
signalling circuits, but one distinct signalling pathway connects at least some of the isolated genes. Comparisons with
microarray data suggest that several genes are dysregulated in specific types of cancers and degenerative diseases.
Conclusions/Significance: Many unknown genes for cell death were revealed through our screen, supporting the enormous
complexity of cell death regulation. Our results will serve as a repository for other researchers working with genomics data
related to apoptosis or for those seeking to reveal novel signalling pathways for cell suicide.
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Introduction
Functional, large-scale genetic screens have been undertaken to
make sense of the abundance of sequence information from the
various genome-wide sequencing projects in order to determine the
function of the novel genes. Given the ease of handling and the
consistency of their experimental conditions, mammalian cell
cultures turned out to be an especially suitable biological system
for these screens [1]. Several loss-of-function screens though RNAi-
mediated gene reduction have been reported [2,3]. However, such
screens only reveal a subset of pathway components, either because
genes often exert redundant functions or the contributions of the
respective factors are too small to be detectable. Hence, gain-of-
function screens for dominant gene activities can likewise reveal
important functional data since the genes can activate signalling
pathways in which their respective proteins are rate-limiting.
Apoptosis is the genetically regulated cell suicide programme. It
is especially amenable to screens since selection schemes cannot be
implemented for dying cells. Moreover, the life/death decision of
the cell is likely to be influenced by many cellular processes with
numerous, possibly so far unknown, positive and negative
regulators. Also, many mediators of apoptosis signals often have
the dominant activity to induce apoptosis when ectopically
expressed as they exert their effect through protein-protein
interactions, which are induced when they are upregulated.
We have established a systematic screen for dominant gene
functions [4,5] named RISCI (robotic single cDNA investigation)
[1]. For this, we grow up individual expression plasmids in
bacteria in a 96-well plate format. The plasmid DNAs are isolated
using a special protocol that yields DNA that is virtually devoid of
endotoxins and allows for efficient transfections of cells in vitro [6].
Since we are testing the activities of individual genes in separate
populations of transfected cells, we obtain favourable signal-to-
noise ratios and a high sensitivity in our functional read-out. Each
of these apoptosis genes, when overexpressed, initiates a signalling
pathway that eventually ends in the active dismantling of the cell.
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25023In a previous study we reported 11 apoptosis-inducing genes
from a manual screen [5], which produced an especially strong
apoptosis phenotype. Some isolates were already known cell death
inducers and served as positive controls. The specificity of this
screen was emphasized by the finding that only particular genes
from gene families were active [7,8,9]. Also, genes that could
potentially activate general stress pathways such as ER stress did
not score positive, nor did dominant-negative genes or constitu-
tively active oncogenes [5]. Importantly, the screen permits the
detection genes that have not been implicated in the apoptosis
response previously. Using additional information from extensive
literature scans and careful sequence analysis we have chosen
some genes for further investigation [5,7,9,10,11,12,13,14]. None
of them were known to induce cell death at the time of their
discovery in our screen and all of them have been shown to
mediate upstream signal for cell death. We have since constructed
custom-made robots for the screen [15,16]. These machines are
highly specialised and permit the screening of large numbers of
genes. Here we reveal the full potential of this screen and present a
comprehensive account of our screening activities with the robots
in combination with a thorough bioinformatics analysis of the
isolated genes.
Results
Isolating of apoptosis inducing genes in a high
throughput screen
We screened a normalized mouse kidney cDNA library for
apoptosis inducers using our experimental screen set-up (Fig. 1A)
in which two steps, the DNA isolation and the transfection, are
performed by custom-made robots. After the DNA isolation robot
had purified the plasmid DNAs, the transfection robot introduced
them individually into cells. Per day this high-throughput screen
achieved 1,536 separate DNA-isolations, -transfections and
activity assays for apoptosis. We used HEK293T cells (human
embryonic kidney cells) as we found them to be easily transfectable
and consistently sensitive to apoptosis inducers. The activity of a
co-transfected and internally expressed b-galactosidase was
measured by the addition of its substrate CPRG (chlorophe-
nolred-ß-D-galactopyranoside) into the medium. The transient co-
transfection of the reporter plasmid compensates differences in the
transfection efficiency between wells. This assay probes the
permeability of the plasma membrane for small molecular weight
reagents upon cell death induction. This is then normalised to the
transfection efficiency, which is revealed upon lysis of the cells.
Figure 1B shows a typical example of a screen result with the ratios
of the CPRG measurements before and after addition of the
detergent plotted against the numbers of wells in a 96-well plate.
Hits were identified when the ratio was higher than 0.5, which
corresponds to a 50% conversion of the CPRG substrate. We have
screened 100,000 expression constructs of a normalized cDNA
library. As the screen is based on scoring cell death by the
permeabilisation of the plasma membrane, which can also be
observed in cell death modes other than apoptosis such as necrosis,
we validated the isolated genes with an enzyme-linked immuno-
sorbent assay (ELISA) that detects the DNA fragments generated
during apoptosis. 75 (87%) of the isolated genes achieved ratios
higher than the green fluoroscent protein (GFP) negative control
and hence were regarded as positive in this assay (Figure 1C). We
also use the cleavage of endogenous PARP (Figure S1), a known
substrate of caspase-3 as an indicator of apoptosis activation [17].
All clones except one showed caspase-3 activity upon ectopic
expression with a general trend in the efficiency similar to the
ELISA assay (Figure 1D). Only those genes were subjected to a
thorough bioinformatics analysis.
Functional annotation of the isolated genes
Figure 2 I records the genes grouped into different functional
categories starting with enzymes and transporters, the two most
prominently represented gene functions, totalling 43 genes,
followed by known apoptosis genes, generic signalling factors,
and genes without a unambiguous functional association (‘‘Oth-
er’’). We also list their Ensembl number, gene name and symbol,
chromosome- and protein accession-number, motifs as well as
biological processes/functions as determined with the database
Biomart. 7 genes (9%) were found to have a known role in
apoptosis regulation, which therefore serve as positive controls:
Among them is the Mitochondrial carrier homolog 1 (Mtch1), also
known as PSAP, a transporter in mitochondria that interacts with
and could mediate apoptosis by presenilin-1 in Alzheimer’s disease
[18]. Three enzymes were among the known apoptosis genes:
cathepsin L, glutathione peroxidase-1, and the GTPase Rhob, all of
which have been shown to mediate apoptosis signals [19,20,21].
Likewise, Itm2b, Fam82a2/PTPIP51, and the mitochondrial fission
factor Fis1 are known as apoptosis regulators [22,23,24]. Itm2b
has been described as a novel BH3-only protein [25] but little else
is know about it. The protein tyrosine phospatase interacting
protein 51 (PTPIP51), also known as Fam82a2, is a substrate for
PTP1B/TCPTP protein tyrosine phosphatases and, based on its
many protein interactions, seems to be positioned at a crucial
nexus for a variety of signalling pathways, including apoptosis
[26]. Fission factors such as Fis1 are likewise well-known apoptosis
mediators [27].
We then determined the subcellular localisation of the apoptosis
factors that we found in the screen from the GO (The Gene
Ontology Consortium [28]) cellular component ontology using
BioMart [29] (Figure 3) and also performed an enrichment
analysis with DAVID (Table S1). Various cellular organelles are
involved in apoptosis regulation and it has been proposed that
each of them contains sensors for cellular damage that can signal
apoptosis [30,31]. This is supported by our findings as we detected
apoptosis proteins in all subcellular compartments. In keeping with
the prominent role of mitochondria for the induction of apoptosis,
this organelle is predicted to harbour the largest number of all
isolates from the screen and of the known apoptosis factors. The
accumulation of apoptosis factors in mitochondria is likely to
reflect the complexity of apoptosis regulation in this organelle. The
number of novel apoptosis regulators localized to this organelle (16
out of 20) indicates that the complexity is even greater than so far
recognized and suggests that the mitochondrion is still a rich
source of so far unknown apoptosis circuits.
The endoplasmic reticulum (ER) is, besides mitochondria,
another well-known membrane-enclosed compartment governing
cell death. Its role for cell death regulation is also underscored by
our results as the organelle with the second largest number of
isolates from the screen. One of the crucial steps by which the ER
contributes to apoptosis is the release of Ca
2+. Consistent with this,
this organelle comprises a number of transporters from the screen
that could, directly or indirectly, facilitate this process. The Golgi
apparatus has only recently been implicated in apoptosis
regulation [32]. During apoptosis this organelle undergoes
dramatic structural changes and eventually disintegrates, most
likely as a result of the cleavage of Golgi proteins. Interestingly,
one of our positive controls for apoptosis, ITM2b is localised to
this organelle. This gene is also known as Bri and is associated with
British familiar dementia [33], possibly by interfering with
amyloid-b (Ab) processing [33]. The peroxisome is mostly known
Apoptosis Signalling Revealed by Genetic Screen
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of peroxisome proliferator receptors, nuclear transcription factors
that mediate an accumulation of peroxisomes, but these organelles
have also other, independent functions [34]. Our data indicate a
pro-apoptotic activity of the peroxisome. Interestingly, the
endosome as well as the lysosome, which develops from an early
endosome, exhibit apoptosis factors. The lysosome is, besides
mitochondria and the ER, another organelle that is thought to
release specific pro-apoptotic factors (such as cathepsin L, Figure 2)
[19]. Also, the endosome has recently emerged as impacting on
apoptosis. A gene from H. pylori causes Bax accumulation at
endosomes and the close alignment of endosomes with mitochon-
dria before Bax is retrieved at mitochondria [35]. The scarcity of
nuclear factors from the screen (7%), relative to the complexity of
this organelle, is noteworthy and possibly reflects that, while
nuclear signals can cause apoptosis, the nucleus is a compartment
that is mostly not required for cell death induction [36].
Interestingly, of all genuine signalling molecules from the screen
Figure 1. Isolation of apoptosis genes with a robotic screen. A. Schematic illustration of the screen for apoptosis genes. Individual bacteria
clones are grown up in 96-deep well plates and their plasmid DNA is harvested using a custom-made DNA isolation robot. A second robotic system
introduces the plasmids into mammalian cells and the cellular effect is detected by a read-out that can be assessed by a plate reader. B. Example of a
b-galactosidase assay result that was used to determine cell death. The ratios of the A590 of CPRG before and after lysis of the cells were determined
40 hours after transfection and are plotted against the well numbers. Well #3 contained the positive control. C. Validation of the cell death genes
using an ELISA specific for apoptosis. Ultra-pure plasmid DNA of the various plasmids were prepared as described in [12] and transfected into HEK
293T cells using jetPEI (PolyPlus) transfection kit. The assay for apoptosis was performed 48 hours post transfection with Cell Death Detection ELISA
(Roche) detecting nucleosomes in cytoplasmic fractions as described by manufacture’s protocol. Absorbance is measured at 405 nm and the
apoptosis enrichment factor calculated as the signal of individual clones against the negative control, GFP. The red and green lines indicate apoptosis
by the positive and negative controls, RIPK1 and GFP, respectively. D. Validation of the cell death genes using a Western blot for PARP cleavage. HEK
293T cells were transfected as under C. and 48 hours later cells were harvested and lysed in RIPA buffer. Proteins were separated on a 12% SDS-PAGE
gel, blotted onto a membrane, and probed with a PARP antibody. Using the programme ImageJ the percentage of cleaved PARP was determined for
each gene.
doi:10.1371/journal.pone.0025023.g001
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the plasma membrane and the cytosol.
According to the information in the PANTHER database the
pie chart in Figure 4a splits the functions into further functional
categories compared to Figure 2, which again illustrates the
abundance of transporters and enzymes among the isolated genes.
The third most prominent functional classification was the binding
category, which supports our view that much of the signalling for
apoptosis is mediated by protein-protein interactions. In agree-
ment with the underrepresentation of nuclear factors from the
screen, only few isolates fall under the category of transcription
regulatory activity.
Clustering the genes for biological processes revealed a
prominent role for transporters and the fact that a substantial
number of genes could not be integrated into a known biological
process and hence are labelled as ‘‘unclassified’’ (Figure 4b). When
we investigated the known signalling pathways represented by the
genes we found that no clustering occurred when using the
PANTHER database (Figure 4c). This suggested that the isolated
factors define signalling pathways that are separate from the ones
they engage in healthy cells. In fact, it is well known that apoptosis
factors often have completely different functions in non-apoptotic
cells [37]. This finding indicates that during apoptosis the
components of the apoptosis signalling pathways are recruited
from a diverse set of signalling circuits that are unrelated to cell
death.
In an effort to connect the isolated genes and define signalling
pathways, we used the Ingenuity Pathways Analysis (IngenuityH
Systems, www.ingenuity.com) and found that several isolates are
linked through the TNF/NF-kB signalling pathway (Figure 5).
This protein complex regulates both pro- and anti-apoptotic genes
and is activated under cell stress conditions. Three target genes
(Gnas, Slc2a1, Slc37a4) were found and Atp1a1 has been reported to
signal via the inositol 1,4,5-trisphosphate receptor to activate NF-
kB [38].
Comparison with microarray data
In figure 6A we compared our isolates with differentially
expressed genes by microarray analysis on breast cancer (two
studies), colon carcinoma (three studies), and prostate cancer
(three studies). We recorded genes that were found both up- and
downregulated (see Methods). Apoptosis genes from the screen
whose expression was reduced would indicate an impairment of
Figure 2. Collection of apoptosis genes isolated by the screen. The identities of the pro-apoptotic genes are listed, allocated to the most
prominent functional categories, enzymes, transporters, apoptosis and signalling factors, together with their ENSEMBL identifiers, gene names,
protein accession numbers, salient InterPro motifs and biological processes from the GO data base. In the last column ‘‘Uncharacterised’’ on its own
means that there are no defined motifs in the respective sequence. ‘‘Uncharacterised-PANTHER’’ entries refers to genes that contain a domain/motif
that has been identified by Panther but the function is unknown.
doi:10.1371/journal.pone.0025023.g002
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were upregulated are likewise of interest as they could indicate
that these cancer cells continue to grow, despite experiencing
pro-apoptotic stress. The oncogene myc, for example, exerts both
a proliferative effect as well as a pro-apoptotic signal [39]. In
those tumour cells anti-apoptotic signalling molecules such as
the Bcl2 family members are potential targets for treatment.
While a considerable heterogeneity in the transcriptional
changes of the genes can be observed, some genes show
consistent alterations. The hemoglobin gene (Hba-a2), for
example, was found to be downregulated in all three cancers.
UDP-glucuronosyltransferase 1–2 Precursor (UDPGT)/Ugt1a10)
and the mitochondrial import inner membrane translocase
subunit (Tim22) gene were reduced in all three colon cancers; as
was the ALEX (Gnas)g e n ei nb o t hb r e a s tc a n c e rs t u d i e s .O nt h e
other hand, the same gene was consistently upregulated in colon
cancer. Interestingly, a recent report confirmed that Gnas is
mutated in several types of cancers [40]. Other upregulated
genes are solute carrier family 2, facilitated glucose transporter
member 1 (Slc2a1) and transmembrane protein 116 (Tmem116).
Abhydrolase domain-containing protein 3 (Abhd3) is upregu-
lated in breast cancer tumours.
We also looked at microarray studies performed on tissues from
degenerative diseases such as Alzheimer’s (2 studies) and
Parkinson’s Disease (7 studies). We reasoned that genes that are
downregulated in these diseases could indicate a response by the
cells to reduce their sensitivity to cell death signals. Hence, we also
present those genes whose transcription level declined. Figure 6B
shows that for the two available microarray studies on Alzheimer’s
only the sodium/potassium-transporting ATPase subunit alpha-1
precursor (Atp1a1) gene was detected as changed (P=0.009).
Except for one gene the transcriptional changes in the Parkinson’s
studies were much more consistent, i.e. the genes are either up- or
downregulated. Many genes contribute only incrementally to the
observed phenotype [41] and the combination of the functional
screen with microarray data could identify this group of genes.
Discussion
Our screen for apoptosis genes has revealed a host of novel
factors that have previously not been implicated in cell death
regulation. Since each isolate is capable to initiate a downstream
signalling pathway that eventually converges on the activation of
the pro-apoptotic caspase proteases, the complexity and the vast
Figure 3. Predicted subcellular distribution of the apoptosis genes. The localisation of the gene products was determined by the GO (The
Gene Ontology Consortium [28]) cellular component ontology using BioMart [29]) and allocated to the respective insert with other genes predicted
to be localised to the same organelle. Multiple listings were allowed. The functional class of each gene is indicated by a number and refers to figure 2.
Key: 1 Enzymes, 2 Transport, 3 Apoptosis, 4 Signalling, 5 Other.
doi:10.1371/journal.pone.0025023.g003
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apparent. While we have isolated a number of positive controls,
most of the genes that are known to regulate apoptosis were so far
not discovered by the screen. Hence, our screen can be regarded
as a first step to cover the whole genome for apoptosis genes,
which will yield a inventory of its signalling nodules and allow
mapping the ‘‘functome’’ [42] of apoptosis. The positive controls
of known apoptosis genes represent less than 10% of the genes
determined in this study (Figure 2) with many apoptosis genes such
as caspases still missing. How many genes in the genome are
involved in apoptosis? If we take as reference a compilation of
known apoptosis genes [43], which lists 110 genes in H. sapiens, and
extrapolate our data on known apoptosis inducers to the complete
genome, assuming that the percentage of so far undiscovered
apoptosis inducers correlates with the percentage of positive
controls from the screen, this would result in a total of more than
1,000 genes involved in apoptosis. This supports the hypothesis
that many additional genes exist that impact on apoptosis.
The smallest group (7% of all isolates) in figure 2 subsumes those
genes that can principally be regarded as signalling factors. The
scarcity of such genes indicates that apoptosis signalling is
performed via different routes compared with most other
signalling pathways. The largest gene group from the screen
comprises enzymes (30%). All enzyme classes were represented
among the isolates except lyases and isomerases. On the other
hand, the occurrence of kinases, the classical signalling mediators
for many other processes such as the cell cycle was only minor
suggesting that many signalling pathways in apoptosis contain
other or additional components. Also, the high number of
transporters (27%) in figure 2 is intriguing. When we clustered
the genes according to their main biological process, we again
discovered a prominent role for transporters (Figure 4b). Apoptosis
can be caused when boundaries between organelles break down.
This is best known for the disruption of the outer mitochondrial
membrane and the release of apoptotic factors such as cytochrome
c and AIF [44]. Indeed, mitochondria have the highest number of
transporter proteins of all organelles (Figure 3), again highlighting
that the process of the permeabilisation of mitochondrial
membranes is crucial for apoptosis. Our results indicate that
additional proteins are involved in this process. This is in
agreement with the fact that the identity of the proteins that
facilitate the loss of the integrity of mitochondrial membranes
during apoptosis and constitute the ‘‘permeability transition pore’’
(PT-pore), is still unresolved [45].
In the apoptosis field the general distinction between extrinsic
and intrinsic pathways is often made [46] with the extrinsic
pathway operating through membrane receptors and the intrinsic
through mitochondria activation. Our functional annotation
indicates that only a minority of genes from the screen code for
receptors (Figure 3) and hence the pathways to report cell stress to
mitochondria are much more divers.
If half of the chemicals in the Sigma catalogue cause apoptosis
at high enough concentrations [47], can it be a good idea to screen
for dominant apoptosis-inducing genes? Might they not only
unspecifically damage the cell and hence reveal little about
apoptosis signalling? Our studies on some of the genes from the
screen indicated that genes closely related to those apoptosis
inducers do not cause apoptosis [9,12]. Of note, we have not
isolated many proteins localised to the ER. An accumulation of
proteins at this organelle can lead to what is subsumed under ‘‘ER
stress’’, and can, if prolonged, cause apoptosis. Control experi-
ments with genes whose proteins are directed through the ER were
negative for apoptosis as were numerous oncogenes and
dominant-negative gene variants [5]. All genes from our screen
induce a downstream apoptosis signalling pathway that ultimately
results in the activation of caspases since both read-outs, the
ELISA (Fig. 1C) which depends on the degradation of the DNA,
and the PARP cleavage (Fig. 1D) are induced by these proteases
[48,49]. We have also employed in the experimental setting of the
screen that the apoptosis response is evolutionary conserved by
using mouse genes in human cells. Collectively, these aspects
indicate that, in contrast to unspecific cell stress exerted by many
small molecular weight compounds [47], the genes from the screen
cause specific signals in the cell that define pro-apoptotic signalling
circuits. Whether the isolated genes also mediate upstream signals
for apoptosis, i.e. whether exogenous signals talk to the
endogenous proteins of our isolates, can only be answered on a
case-by-case basis. With those genes that we further investigated,
we found that upstream signals for apoptosis were indeed inhibited
when the genes were inactivated [5,7,9,10,50]. Our results with
microarrays (Figure 6) indicate that the genes from the screen are
potentially also involved in disease scenarios. Given that apoptosis
is an active response by the cells, similar to other differentiation
programmes, we speculate that eventually all of the isolates can be
integrated into a physiological or pathological context of apoptosis
induction.
One of the most important applications of the apoptosis genes
presented in this work will be the annotation of genes that are
differentially expressed by microarray analysis, which we exem-
plified in figure 6. Our functional data can in particular contribute
Figure 4. Allocation of the apoptosis genes to functions, biological processes and signalling pathways. A. The pie chart depicts the
allocation of the apoptosis genes to molecular functions according to the PANTHER database. B. Grouping of the main biological processes governed
by the genes from the screen. C. Assembly of the known signalling pathways that are regulated by the genes from the screen.
doi:10.1371/journal.pone.0025023.g004
Figure 5. Signalling pathway identifications. Signalling pathway
links were generated through the use of Ingenuity Pathways Analysis
(IngenuityH Systems, www.ingenuity.com).
doi:10.1371/journal.pone.0025023.g005
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underlying tumourigenesis in the ‘‘cancer genome’’ from those
that are mere ‘‘passengers’’ [51]. As it is the upregulation of the
genes that activates them for apoptosis, we would expect that it
complements microarray data, which record such transcriptional
changes. This combination will add an important functional aspect
to the correlative data produced by microarrays. A case in point is
the determination of hemoglobin as an apoptosis inducer in our
screen (Figure 2) and in microarray analysis [52]. While surprising,
hemoglobin has been found in later studies to be upregulated in
various cell types and responsible for apoptosis [53,54].
After our first reports on the apoptosis screen [4,5,55] and its
technology [15,16,56] similar screens for dominant apoptosis
inducers were published by other groups [57]. One approach
isolated a number of genes that were described as potential tumour
suppressor genes [58]. Other researchers screened and identified
three genes out of 938 hypothetical genes as apoptosis inducers
using standard transfections in combination with subcellular
imaging, western blotting, and DNA fragmentation ELISA [59].
The most comprehensive effort so far to screen for cell death-
inducing genes was performed by testing pools of genes each
comprising 96 cDNAs from a T-cell library. This screen produced,
besides factors that also induce alternative phenotypes of cell
death, 64 genes for apoptosis induction [60]. Interestingly, only
three genes (MTCH1, GNAS, SDHC) overlap with our gene
collection possibly indicating differences between the libraries
used. Other technical approaches have been employed to screen
for apoptosis mediators. Reverse transfection cell array technology
(45) arrays the transfection mixes, each containing an individual
gene of interest, onto glass slides, which are then overlaid with
cells. With this approach a collection of 382 human sequence-
verified, full-length open reading frames were screened for
Figure 6. Differential expression of 71 human orthologues of the 74 mouse genes in publically available gene expression datasets.
Not all 71 of the human orthologues were found to be differentially expressed within the publically available datasets at a 20% FDR rate. The
numbers are fold changes; red represents an over-expression of the disease cell type and green represents an under-expression of the disease
phenotypes. Both human and mouse Ensembl IDs are given as well as the dataset ArrayExpress ID. A.) Breast, colon and prostate cancer disease
types. B.) Alzheimer’s and Parkinson’s disease types.
doi:10.1371/journal.pone.0025023.g006
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array screen was also performed with 1,959 mammalian open
reading frames from the Mammalian Genome Collection with 10
proapoptotic genes eventually being verified (46).
In summary, we believe that this study demonstrates that testing
gene activities by individual transfections holds great promise to
the definition of the functome of apoptosis and can have
applications in other functional read-outs as well.
Materials and Methods
Screening
The various steps of the screening procedure were performed as
described using our custom-made robots [5,15,55]. The DNA
isolation robot performed our special protocol of DNA isolation
that yields exceptionally pure DNA that can be transfected
efficiently into cells and does not generate background cell death –
as published [16]. Some of the description is available online as
part of our publication of the DNA isolation robot [16]. Screening
was done in duplicates. Only these genes that are active in both
assays were regarded as positive. An expression vector for
luciferase was used as negative control. The integrity of the cell
membrane was probed by adding the b-galactosidase substrate
CPRG, which can enter dying cells and is converted into a
coloured product by the enzyme. The cells are then lysed by
TritonX-100 in order to normalize for the transfection efficiency
[15]. For the read-out we made use of the FLUOROstar
microplate reader from BMG Labtech and the data were
processed by the Windows-based OPTIMA software on a DELL
Dimension 3100 computer.
Apoptosis detection
The Cell Death Detection ELISA (Roche), which detects
nucleosomes in cytoplasmic fractions, was used as described in
manufacture’s protocol. For the PARP Western blotting HEK
293T cells were transfected using jetPEI transfection kit (Polyplus-
transfection, France) according to manufacturer’s protocol.
48 hours post transfection the cells were lysed with RIPA buffer.
Western blot was performed with a PARP antibody (Cell
Signalling #9542) and developed with ECL (Pierce) and
Amersham Hyperfilm (GE Healthcare). Analysis and quantifica-
tion of the proteins was performed using ImageJ.
Bioinformatics analysis
The associated Ensembl [61] gene IDs for the mouse cDNAs
were identified by BLAST [62] using blastx to search the Ensembl
peptide database (NCBIM37.58). Using the identified Ensembl
gene IDs the gene names, UniProt accessions, InterProScan [63]
motif/domain information and GO (The Gene Ontology
Consortium [28]) biological process, molecular function and
cellular location information were all extracted from the Ensembl
Genes 58 Mus musculus genes (NCBIM37) dataset in BioMart
[29]. The PANTHER [64,65] molecular function and pathway
information was obtained from the PANTHER web site (version
7.0) using the Ensembl gene IDs.
Differential gene expression studies
Publically available gene expression datasets for breast, colon
and prostate cancer as well as Parkinson’s disease and Alzheimer’s
disease were downloaded in a processed format. The datasets were
either Affymetrix GeneChip Human Genome HG-U133A,
Affymetrix GeneChip Human Genome HG-U133B or Affymetrix
GeneChip Human Genome U133 Plus 2.0 gene chips. The gene
expression datasets were analyzed in R using the affy [66] and
preprocessCore [67] Bioconductor [68] packages. Each gene
expression dataset was log transformed and normalized by
quantiles across the array. Probes were then filtered out by the
Affymetrix detection calls, whereby probes that were ‘‘present’’ or
‘‘marginal’’ were kept and those that were ‘‘absent’’ were
removed. The probes that were the least varying, the bottom
10% as determined by the coefficient of variation, were removed
as well. For datasets containing multiple tissues, each analysis was
performed within tissues. Differentially expressed genes were
identified using the Significance Analysis of Microarrays (SAM),
found in the siggenes [69] package in Bioconductor. SAM utilizes a
modulated t-test to determine differential expression and permu-
tation tests were used to correct for multiple testing. Differentially
expressed genes were identified at a False Discovery Rate of
,20% for comparison with the mouse apoptosis genes. 71 out of
74 mouse apoptosis genes had human orthologues; figure 6 shows
which of those genes were differentially expressed for a given
dataset. For each gene present, the fold change was calculated
whereby the values .1 represent over-expression in the disease
state.
Supporting Information
Figure S1 Accumulation of cleaved PARP as an assay for
caspase-3 activity. A Western blot of extracts from cells
transfected with a selection of clones with a representative range of
different PARP cleavage activities together with negative (pGL)
and positive (RIPK1) controls is shown. Equal loading was verified
with b-actin (bottom). Band intensities and conversion ratios were
calculated with ImageJ (top).
(TIF)
Table S1 Enrichment of GO and pathway (KEGG and
Panther) terms within the 74 mouse genes. The enrich-
ment analysis was performed in DAVID* with the search results
restricted to gene ontology (GO) terms and KEGG and Panther
Pathways. The terms highlighted in blue are significant at a 10%
FDR level, as determined by the Benjamini method. The GO/
Pathway identifiers are listed along with the genes involved and
the relevant statistics.
(XLS)
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